Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections

Ophthalmology

Volumn 119, Issue 8, 2012, Pages 1609-1614

  Cheung, Crystal S Y ^a   Wong, Amanda W T ^a   Lui, Alex ^a   Kertes, Peter J ^b   Devenyi, Robert G ^a   Lam, Wai Ching ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

AGED; ANTIBIOTIC PROPHYLAXIS; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CHORIORETINOPATHY; COMPARATIVE STUDY; CONFERENCE PAPER; DIABETIC MACULAR EDEMA; DRUG INDICATION; ENDOPHTHALMITIS; HUMAN; INFECTION RATE; INFECTION RISK; INTRAVITREAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; SURGEON;

AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; FEMALE; FLUOROQUINOLONES; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84864458918     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.02.014     Document Type: Conference Paper

References (34)

1. J.O. Mason III, M.F. White, R.M. Feist Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection Retina 28 2008 564 567
2. I.U. Scott, H.W. Flynn Jr Reducing the risk of endophthalmitis following intravitreal injections Retina 27 2007 10 12
3. A.E. Fung, P.J. Rosenfeld, E. Reichel The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide Br J Ophthalmol 90 2006 1344 1349
4. S. Pilli, A. Kotsolis, R.F. Spaide Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting Am J Ophthalmol 145 2008 879 882
5. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 335 2006 1432 1444
6. M.G. Speaker, J.A. Menikoff Prophylaxis of endophthalmitis with topical povidone-iodine Ophthalmology 98 1991 1769 1775
7. A.R. Bhavsar, M.S. Ip, A.R. Glassman DRCRnet Study Group SCORE Study Group The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials Am J Ophthalmol 144 2007 454 456
8. A.R. Bhavsar, J.M. Googe Jr, C.R. Stockdale Diabetic Retinopathy Clinical Research Network Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network Laser-Ranibizumab-Triamcinolone Clinical Trials Arch Ophthalmol 127 2009 1581 1583
9. S.B. Bhatt, K.M. Stepien, K. Joshi Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate Retina 31 2011 2032 2036
10. C.N. Ta, P.R. Egbert, K. Singh Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery Ophthalmology 109 2002 2036 2040
11. J.M. Moss, S.R. Sanislo, C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
12. A.E. Green-Simms, N.S. Ekdawi, S.J. Bakri Survey of intravitreal injection techniques among retinal specialists in the United States Am J Ophthalmol 151 2011 329 332
13. S.J. Kim, H.S. Toma, N.K. Midha Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections Ophthalmology 117 2010 2372 2378
14. P. Costello, S.J. Bakri, P.M. Beer Vitreous penetration of topical moxifloxacin and gatifloxacin in humans Retina 26 2006 191 195
15. S.J. Kim, H.S. Toma Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 2011 1358 1363
16. D. Miller, P.M. Flynn, I.U. Scott In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 2006 479 483
17. D.C. Hooper Fluoroquinolone resistance among Gram-positive cocci Lancet Infect Dis 2 2002 530 538
18. H. Mino de Kasper, A.S. Hoepfner, M. Engelbert Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermis endophthalmitis in a rabbit model Ophthalmology 108 2001 470 478
19. Y. Yospaiboon, S. Saree, S. Pasadhika Blood culture and conventional media for vitreous culture in infectious endophthalmitis J Med Assoc Thai 88 2005 639 642
20. F.M. Recchia, B.G. Busbee, R.B. Pearlman Changing trends in the microbiologic aspects of postcataract endophthalmitis Arch Ophthalmol 123 2005 341 346
21. T.L. Jackson, S.J. Eykyn, E.M. Graham, M.R. Stanford Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases Surv Ophthalmol 48 2003 403 423
22. C. Chiquet, P.L. Cornut, Y. Benito French Institutional Endophthalmitis Study (FRIENDS) Group Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis Invest Ophthalmol Vis Sci 49 2008 1971 1978
23. C.A. McCannel Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 321 2011 654 661
24. R.D. Jager, L.P. Aiello, S.C. Patel, E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698
25. D.M. Moshfeghi, P.K. Kaiser, I.U. Scott Acute endophthalmitis following intravitreal triamcinolone acetonide injection Am J Ophthalmol 136 2003 791 796
26. A.C. Westfall, A. Osborn, D. Kuhl Acute endophthalmitis incidence: intravitreal triamcinolone Arch Ophthalmol 123 2005 1075 1077
27. M.L. Nelson, M.T. Tennant, A. Sivalingam Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection Retina 23 2003 686 691
28. S.J. Bakri, A. Shah, N.S. Falk, P.M. Beer Intravitreal preservative-free triamcinolone acetonide for treatment of macular oedema Eye (Lond) 19 2005 686 688
29. S.J. Bakri, A.O. Edwards, S.M. Couch Noninfectious endophthalmitis occurring after intravitreal triesence injection Retin Cases Brief Rep 3 2009 316 318
30. J.C. Pastor, M.J. Del Nozal, E. Zamarron, M. Garcia Solubility of triamcinolone acetonide and other anti-inflammatory drugs in silicone oil: implications for therapeutic efficacy Retina 28 2008 1247 1250
31. Z.D. Inman, N.G. Anderson Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia Retina 31 2011 669 672
32. O. Artunay, E. Yuzbasioglu, R. Rasier Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection Eye (Lond) 23 2009 2187 2193
33. D. Mezad-Koursh, M. Goldstein, G. Heilwail Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor Retina 30 2010 1051 1057
34. S.S. Wickremasinghe, K. Michalova, J. Gilhotra Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration Ophthalmology 115 2008 1911 1915